Mesoblast Limited (NASDAQ:MESO) – Research analysts at Cantor Fitzgerald boosted their FY2018 earnings estimates for Mesoblast Limited in a note issued to investors on Wednesday. Cantor Fitzgerald analyst E. Piros now forecasts that the company will post earnings of ($1.16) per share for the year, up from their prior estimate of ($1.18). Cantor Fitzgerald has a “Buy” rating and a $20.00 price objective on the stock.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/fy2018-earnings-forecast-for-mesoblast-limited-issued-by-cantor-fitzgerald-meso/1538122.html.

A number of other equities analysts have also commented on MESO. Zacks Investment Research lowered Mesoblast Limited from a “buy” rating to a “sell” rating in a research note on Wednesday, May 17th. Maxim Group set a $14.00 price objective on Mesoblast Limited and gave the stock a “buy” rating in a research note on Thursday, May 25th. BidaskClub lowered Mesoblast Limited from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Credit Suisse Group set a $11.00 price objective on Mesoblast Limited and gave the stock a “hold” rating in a research note on Tuesday, July 18th. Finally, Oppenheimer Holdings, Inc. initiated coverage on Mesoblast Limited in a research note on Thursday. They issued an “outperform” rating and a $16.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $13.64.

Shares of Mesoblast Limited (NASDAQ:MESO) traded up 1.52% on Friday, reaching $6.00. The company had a trading volume of 113,923 shares. Mesoblast Limited has a 52-week low of $4.01 and a 52-week high of $12.50. The company has a 50-day moving average price of $6.99 and a 200-day moving average price of $8.25. The firm’s market capitalization is $509.30 million.

An institutional investor recently raised its position in Mesoblast Limited stock. Princeton Capital Management Inc. increased its position in shares of Mesoblast Limited (NASDAQ:MESO) by 15.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 155,700 shares of the company’s stock after buying an additional 20,945 shares during the period. Princeton Capital Management Inc. owned about 0.20% of Mesoblast Limited worth $1,398,000 as of its most recent SEC filing. 2.95% of the stock is currently owned by hedge funds and other institutional investors.

Mesoblast Limited Company Profile

Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.